Question 1

Am I eligible for this trial based on my kidney function and overall health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease clinical trial (NCT06430684). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of taking empagliflozin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease clinical trial (NCT06430684). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease clinical trial (NCT06430684). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the clinic visits and phone check-ins?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease clinical trial (NCT06430684). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this trial compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease clinical trial (NCT06430684). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I am not selected to receive the new treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease clinical trial (NCT06430684). Contact the study team or your healthcare provider for specific answers.

What this study is about